Metrics as of 10/15/2026, 11:18 PM (Berlin time), refresh in progress.
Cumberland Pharmaceuticals Stock
Cumberland Pharmaceuticals Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- CEO
- A. J. Kazimi
- Employees
- 88
- Market cap
- $113 M
- IPO
- 11/08/2009
Cumberland Pharmaceuticals Inc. functions as a specialized pharmaceutical enterprise, primarily involved in the procurement, advancement, and commercialization of prescription medications. Its strategic focus areas include acute hospital care, gastroenterology, rheumatology, and oncology, with operations spanning both…
Cumberland Pharmaceuticals stock: price history
1D
+0.7%
1W
+8.0%
1M
+13.6%
6M
+144.0%
YTD
+89.4%
1Y
+119.2%
2Y
+503.2%
5Y
+175.2%
10Y
+52.0%
Next earnings date
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~40% stronger price swings than usual
Ask the agents about Cumberland Pharmaceuticals
Analyst assessment of Cumberland Pharmaceuticals
0
STRONG BUY
3
BUY
2
HOLD
0
SELL
0
STRONG SELL
5
TOTAL · Buy
As of: 03/12/2019
Cumberland Pharmaceuticals stock metrics
P/E
-10.55
P/B
6.48
EV/EBITDA
-22.43
RETURN ON EQUITY
-23.6%
NET MARGIN
-2,472.5%
DEBT/EQUITY
0.27
DIVIDEND YIELD
19.9%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
58.4%
FLOAT SHARES
8,750,190
AVG. DAILY VOLUME (30D)
37,312
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about Cumberland Pharmaceuticals stock
What does Cumberland Pharmaceuticals do?
Cumberland Pharmaceuticals Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United States.
The CEO is A. J. Kazimi, the company employs around 88 people.
The IPO was on 11/08/2009; the stock trades on NASDAQ under the ticker CPIX.
What do analysts say about Cumberland Pharmaceuticals stock?
5 analysts rate the stock, the consensus is Buy (as of 03/12/2019).
This is an external assessment, not a statement by Market Jury.
When does Cumberland Pharmaceuticals report next?
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 40% stronger than usual.
Does Cumberland Pharmaceuticals pay a dividend?
Yes. The last dividend was US$1.50 per share.
The dividend yield is 19.9% (as of 30/06/2026).
Which stocks are comparable to Cumberland Pharmaceuticals?
Comparable stocks include Zoetis, Viatris, Lantheus Holdings, Amneal Pharmaceuticals, Indivior Pharmaceuticals, Eton Pharmaceuticals, Pacira BioSciences and Amphastar Pharmaceuticals.
How can I get Cumberland Pharmaceuticals stock analyzed?
Clicking "Analyze stock" lets five strategies assess Cumberland Pharmaceuticals against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.